Skip to Main Content (Press Enter)

Logo UNISR
  • ×
  • Home
  • People
  • Outputs
  • Organizations
  • Expertise & Skills

UNIFIND
Logo UNISR

|

UNIFIND

unisr.it
  • ×
  • Home
  • People
  • Outputs
  • Organizations
  • Expertise & Skills
  1. Outputs

Monitoring of neoadjuvant chemotherapy through time domain diffuse optics: breast tissue composition changes and collagen discriminative potential

Academic Article
Publication Date:
2024
Short description:
Monitoring of neoadjuvant chemotherapy through time domain diffuse optics: breast tissue composition changes and collagen discriminative potential / Mule, N.; Maffeis, G.; Cubeddu, R.; Santangelo, C.; Bianchini, G.; Panizza, P.; Taroni, P.. - In: BIOMEDICAL OPTICS EXPRESS. - ISSN 2156-7085. - 15:8(2024), pp. 4842-4858. [10.1364/BOE.527968]
abstract:
The purpose of this clinical study is to test a broad spectral range (635-1060 nm) time-domain diffuse optical spectroscopy in monitoring the response of breast cancer patients to neoadjuvant chemotherapy (NAC). The broadband operation allows us to fully analyze tissue composition in terms of hemoglobin, water, lipids and collagen concentration, which has never been systematically studied until now during the course of therapy. Patients are subjected to multiple breast optical imaging sessions, each one performed at different stages of NAC, both on tumor-bearing and contralateral healthy breasts. We correlate the optical results with conventional imaging techniques and pathological response. Preliminary outcomes on 10 patients’ data show an average significant reduction in the concentrations of oxy-hemoglobin (-53%, p = 0.0020), collagen (-36%, p = 0.0039) and water (-15%, p = 0.0195), and increase in lipids (+39%, p = 0.0137) from baseline to the end of therapy in the tumor-bearing breast of patients who responded to therapy at least partially. With respect to scattering, the scattering amplitude, a, increases slightly (+15%, p = 0.0039) by the end of the therapy compared to the baseline, while the scattering slope, b, shows no significant change (+4%, p = 0.9219). Some change in the constituents’ concentrations was also noticed in the contralateral healthy breast, even though it was significant only for oxy-hemoglobin concentration. We observed that collagen seems to be the only component distinguishing between complete and partial responders by the end of 2-3 weeks from the baseline. In the complete responder group, collagen significantly decreased after 2-3 weeks with respect to baseline (p = 0.0423). While the partial responder group also showed a decrease, it did not reach statistical significance (p = 0.1012). This suggests that collagen could serve as a potential biomarker to measure NAC effectiveness early during treatment. Even though obtained on a small group of patients, these initial results are consistent with those of standard medical modalities and highlight the sensitivity of the technique to changes that occur in breast composition during NAC.
Iris type:
1.1 Articolo in rivista
List of contributors:
Mule, N.; Maffeis, G.; Cubeddu, R.; Santangelo, C.; Bianchini, G.; Panizza, P.; Taroni, P.
Authors of the University:
BIANCHINI GIAMPAOLO
Handle:
https://iris.unisr.it/handle/20.500.11768/172668
Full Text:
https://iris.unisr.it//retrieve/handle/20.500.11768/172668/315555/boe-15-8-4842.pdf
Published in:
BIOMEDICAL OPTICS EXPRESS
Journal
  • Overview

Overview

URL

https://opg.optica.org/boe/fulltext.cfm?uri=boe-15-8-4842&id=553989
  • Use of cookies

Powered by VIVO | Designed by Cineca | 26.5.0.0